Published in Am J Pathol on January 01, 1997
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2008) 2.44
Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A (2003) 2.12
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci U S A (2000) 1.97
Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.60
Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med (2008) 1.24
TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J Biol Chem (2004) 1.18
Up-regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol Biol Cell (2006) 1.17
Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals (Basel) (2010) 1.13
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
Programmed cell death in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.04
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem (2011) 0.96
Role of glial cells in neurotoxin-induced animal models of Parkinson's disease. Neurol Sci (2010) 0.92
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci U S A (1999) 0.92
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci (2004) 0.90
Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc Natl Acad Sci U S A (2000) 0.86
Loss of functional alpha-synuclein: a toxic event in Parkinson's disease? J Parkinsons Dis (2012) 0.86
Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice. Neurobiol Aging (2013) 0.86
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease. J Neurochem (2016) 0.85
Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy. Pathophysiology (2012) 0.83
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci (2016) 0.80
Diverse cell death pathways result from a single missense mutation in weaver mouse. Am J Pathol (1997) 0.79
Parkinson's disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein. BMC Neurosci (2013) 0.78
Increasing the Detection Limit of the Parkinson Disorder through a Specific Surface Chemistry Applied onto Inner Surface of the Titration Well. J Funct Biomater (2012) 0.78
Atomic force microscopy based nanoassay: a new method to study α-Synuclein-dopamine bioaffinity interactions. Sci Rep (2014) 0.75
Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Apoptosis and Glial Cell-Derived Neurotrophic Factor: in vivo and in vitro. Front Aging Neurosci (2016) 0.75
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Diagnosis of Alzheimer's disease. Arch Neurol (1985) 12.77
Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol (1995) 9.35
Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain (1991) 8.16
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology (1988) 6.79
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) (1990) 6.11
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry (1993) 3.95
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79
Diffuse Lewy body disease in Japan. J Neurol (1990) 3.61
Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med (1993) 3.58
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41
Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? Arch Neurol (1989) 3.24
Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 2.84
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol (1993) 2.67
Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu (1982) 2.54
A radical hypothesis for neurodegeneration. Trends Neurosci (1993) 2.50
Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol (1988) 2.28
Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl (1993) 2.27
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci (1990) 2.24
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol (1993) 2.07
The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell (1993) 2.01
Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem (1994) 1.93
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation. Science (1988) 1.79
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature (1995) 1.79
Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78
In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature (1995) 1.75
Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett (1994) 1.71
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 1.69
Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology (1991) 1.69
Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol (1976) 1.61
Defining apoptosis. Am J Pathol (1995) 1.60
In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron (1993) 1.58
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (1989) 1.52
Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med (1993) 1.51
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci (1995) 1.50
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (1995) 1.40
Diffuse Lewy body disease. Lancet (1989) 1.40
Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem (1994) 1.35
Interaction between chemicals and melanin. Pigment Cell Res (1993) 1.34
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Parkinson's disease. Br Med J (Clin Res Ed) (1986) 1.23
Cell death in the embryonic chick spinal cord. J Cell Biol (1974) 1.19
Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol (1994) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport (1995) 1.12
Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes. J Neuropathol Exp Neurol (1995) 1.03
Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci (1994) 1.02
The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest (1995) 1.01
Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett (1994) 0.97
The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease. Neurosci Lett (1989) 0.97
Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine. Exp Cell Res (1993) 0.96
Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol (1985) 0.95
Encephalitis with acute Parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci (1971) 0.93
Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci U S A (1994) 0.86
Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (1994) 0.85
Neuropathology in movement disorders. J Neurol Neurosurg Psychiatry (1989) 0.83
Toward a definition of Parkinson's disease. Neurology (1989) 0.81
Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol (1995) 0.79
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology (2003) 2.97
Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol (1991) 1.86
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension (2001) 1.41
Contribution of somal Lewy bodies to neuronal death. Brain Res (1997) 1.25
Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology (2003) 0.99
Alzheimer's disease: a review concerning immune response and microischemia. Med Hypotheses (2001) 0.91
Preliminary findings of high-dose thiamine in dementia of Alzheimer's type. J Geriatr Psychiatry Neurol (1994) 0.91
Is nuclear factor-kappaB a good treatment target in brain ischemia/reperfusion injury? Neuroreport (2000) 0.90
Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology (Berl) (2002) 0.88
Human olfactory epithelium in normal aging, Alzheimer's disease, and other neurodegenerative disorders. J Comp Neurol (1991) 0.87
Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol (1993) 0.86
Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat (2009) 0.86
Erythrocyte membrane alterations associated with the attachment and replication of Eperythrozoon suis: a light and electron microscopic study. Vet Pathol (1985) 0.84
Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease. Brain Res (1992) 0.83
Dietary factors and cognitive impairment in community-dwelling elderly. J Nutr Health Aging (2007) 0.81
Microcystin-LR-induced ultrastructural changes in rats. Vet Pathol (1990) 0.79
Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2. J Immunol (1989) 0.79
Abortion and perinatal foal mortality associated with equine herpesvirus type 1 in a herd of Grevy's zebra. J Am Vet Med Assoc (1986) 0.78
Cell therapy for ischaemic stroke. Cell Prolif (2011) 0.77
Hypertonic mannitol loading of NF-kappaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1. Stroke (2000) 0.77
Vulnerability of the neuronal cytoskeleton in aging and Alzheimer disease: widespread involvement of all three major filament systems. Annu Rev Gerontol Geriatr (1990) 0.77
Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol (1996) 0.77
Cloacal papillomas in psittacines. Am J Vet Res (1986) 0.77
Comparison of a cheetah herpesvirus isolate to feline herpesvirus type 1. Arch Virol (1988) 0.77
Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome. Ann Otol Rhinol Laryngol (1995) 0.77
Visualization of cytoskeletal elements and associated retroviral antigens by immunogold transmission electron microscopy of detergent extracted cells. Scan Electron Microsc (1986) 0.76
Senile plaques exert no mass lesion effect on surrounding neurons. J Neurosci Methods (2001) 0.75
Multinucleate enterocytes associated with experimental group A porcine rotavirus infection. Vet Pathol (1990) 0.75
Genetic contributions to self-reported tiredness. Mol Psychiatry (2017) 0.75
Characterization of the distinctive neurofilament subunits of the soma and axon initial segments in the squid stellate ganglion. J Neurosci Res (1990) 0.75
Plasma alkaline phosphatase in mice with experimentally-induced osteosarcomas. Lab Anim Sci (1976) 0.75
Axonal neurofilaments differ in composition and morphology from those in the soma of the squid stellate ganglion. Cell Motil Cytoskeleton (1988) 0.75